This article reviews the structures and biological activities of several classes of uridine-containing nucleoside antibiotics (tunicamycins, mureidomycins/pacidamycins/sansanmycins, liposidomycins/caprazamycins, muraymycins, capuramycins) that target translocase MraY on the peptidoglycan biosynthetic pathway. In particular, recent advances in structure-function studies, and recent X-ray crystal structures of translocase MraY complexed with muraymycin D2 and tunicamycin are described. The inhibition of other phospho-nucleotide transferase enzymes related to MraY by nucleoside antibiotics and analogues is also reviewed
Muraymycins are antibacterial natural products from Streptomyces spp. that inhibit translocase I (Mr...
Mycobacterium tuberculosis (Mtb) has recently surpassed HIV/AIDS as the leading cause of death by a ...
The rapid increase in antibiotic-resistant bacteria has emphasized the urgent need to identify new t...
Muraymycins are a subclass of naturally occurring nucleoside antibiotics with promising antibacteri...
Antibiotic-resistance has become a widespread problem in the United States and across the globe. Mea...
Every year there has been a growing increase in infections caused by strains of bacteria resistant t...
The quest for new antibiotics, especially those with activity against Gram-negative bacteria, is urg...
This review covers recent developments in the inhibition of translocase MraY and related phospho-Glc...
The quest for new antibiotics, especially those with activity against Gram-negative bacteria, is urg...
Muraymycins are a promising class of antimicrobial natural products. These uridine-derived nucleosid...
The present status of antibiotic research requires the urgent invention of novel agents that act on ...
Antibiotic resistance happens when bacteria develop the ability to survive medications that normally...
Novel antibiotics are urgently needed to combat the rise of infections due to drug-resistant microor...
New antibiotics with novel targets or mechanisms of action are needed to counter the steady emergenc...
Nucleoside analogues have found widespread application as antiviral and antitumor agents, but not ye...
Muraymycins are antibacterial natural products from Streptomyces spp. that inhibit translocase I (Mr...
Mycobacterium tuberculosis (Mtb) has recently surpassed HIV/AIDS as the leading cause of death by a ...
The rapid increase in antibiotic-resistant bacteria has emphasized the urgent need to identify new t...
Muraymycins are a subclass of naturally occurring nucleoside antibiotics with promising antibacteri...
Antibiotic-resistance has become a widespread problem in the United States and across the globe. Mea...
Every year there has been a growing increase in infections caused by strains of bacteria resistant t...
The quest for new antibiotics, especially those with activity against Gram-negative bacteria, is urg...
This review covers recent developments in the inhibition of translocase MraY and related phospho-Glc...
The quest for new antibiotics, especially those with activity against Gram-negative bacteria, is urg...
Muraymycins are a promising class of antimicrobial natural products. These uridine-derived nucleosid...
The present status of antibiotic research requires the urgent invention of novel agents that act on ...
Antibiotic resistance happens when bacteria develop the ability to survive medications that normally...
Novel antibiotics are urgently needed to combat the rise of infections due to drug-resistant microor...
New antibiotics with novel targets or mechanisms of action are needed to counter the steady emergenc...
Nucleoside analogues have found widespread application as antiviral and antitumor agents, but not ye...
Muraymycins are antibacterial natural products from Streptomyces spp. that inhibit translocase I (Mr...
Mycobacterium tuberculosis (Mtb) has recently surpassed HIV/AIDS as the leading cause of death by a ...
The rapid increase in antibiotic-resistant bacteria has emphasized the urgent need to identify new t...